Molecule intelOpportunity: Moderate0

Hypromellose

6 brands · 5 companies · product forms

Opportunity snapshot

Launch attractiveness
45
Market saturation
13
Price room
100
Regulatory risk
0
6
brands
5
companies
Rs 338.25
median price
4
price points
5.62x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 17%

1 brands · 17%
1 brands · 17%
1 brands · 17%

Price room

Across observed sources and strengths
CheapestRs 321.6
MedianRs 338.25
Most expensiveRs 1,805.89
Spread5.62×
Sources: DVAGO, Servaid

max/min price ratio 5.62x across 4 trusted points (Rs 321.6-1805.89). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 4 live products for Hypromellose — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(12) + 25% price-variation(100) + 20% low-competition(87) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

5 canonical companies and 6 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 5.62x across 4 trusted points (Rs 321.6-1805.89). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.